分子诊断市场规模、份额、成长分析（按产品、按检测类型、按样本类型、按技术、按应用、按最终用户、按地区）- 行业预测 2025-2032

2023 年全球分子诊断市场规模为 158 亿美元，预计将从 2024 年的 168.9 亿美元成长到 2032 年的 288 亿美元，预测期内（2025-2032 年）的复合年增长率为 6.9%。

随着技术进步、感染疾病流行率的上升以及个人化医疗的兴起，全球分子诊断市场预计将显着增长。此领域涵盖与多种疾病相关的生物分子的检测和表征，包括感染疾病、肿瘤学、遗传性疾病和药物基因组学。 PCR、NGS 和微阵列等最新技术创新提高了测试的敏感性和特异性，从而可以更快、更准确地进行诊断。由于爱滋病毒和肝炎等感染疾病的增加、人口老化以及慢性病的流行，市场正在显着增长，这些疾病都需要可靠的分子诊断来进行早期发现和有针对性的治疗。雅培、罗氏和赛默飞世尔等主要企业正积极寻求策略伙伴关係和产品创新，以巩固其市场地位。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 专利分析
• 监管分析
• 技术分析
• 案例研究

分子诊断市场规模（按产品和复合年增长率） (2025-2032)

• 市场概览
• 试剂和套件
• 装置
• 服务和软体

分子诊断市场规模（按测试类型和复合年增长率） (2025-2032)

• 市场概览
• 实验室筛检
• POC 测试

分子诊断市场规模（按样本类型和复合年增长率） (2025-2032)

• 市场概览
• 血液、血清、血浆
• 尿
• 其他样本类型

分子诊断市场规模（依技术及复合年增长率） (2025-2032)

• 市场概览
• 聚合酵素链锁反应
• 恒温核酸增幅技术
• DNA定序与次世代定序
• 原位杂交
• DNA微阵列
• 其他技术

分子诊断市场规模（依应用划分）及复合年增长率（2025-2032）

• 市场概览
• 感染疾病诊断
  • 肝炎
  • B型肝炎
  • C型肝炎
  • 其他肝炎疾病
  • HIV
  • CT/NG
  • 高的
  • HPV
  • 结核
  • 流感
  • 其他感染疾病
• 肿瘤学检测
  • 乳癌
  • 大肠直肠癌
  • 肺癌
  • 摄护腺癌
  • 其他类型的癌症
• 基因检测
• 其他用途

分子诊断市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概览
• 诊断实验室
• 医院和诊所
• 其他最终用户

分子诊断市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• F. Hoffmann-La Roche Ltd.（Switzerland）
• Hologic, Inc.（US）
• Abbott Laboratories（US）
• Illumina, Inc.（US）
• Thermo Fisher Scientific Inc.（US）
• bioMerieux（France）
• QIAGEN（Netherlands）
• Becton Dickinson And Company（US）
• Grifols SA（Spain）
• Bio-Rad Laboratories, Inc.（US）
• Sysmex Corporation（Japan）
• Quidel Corporation（US）
• Biocartis（Belgium）
• DiaSorin（Italy）
• Myriad Genetics（US）
• Revvity（US）
• MDxHealth（Belgium）
• OncoCyte Corporation（US）

结论和建议

Global Molecular Diagnostics Market size was valued at USD 15.8 billion in 2023 and is poised to grow from USD 16.89 billion in 2024 to USD 28.8 billion by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032).

The global molecular diagnostics market is poised for significant growth, driven by advancements in technology, increasing prevalence of infectious diseases, and the rise of personalized medicine. This sector encompasses the detection and characterization of biomolecules related to various conditions, including infectious diseases, oncology, genetic disorders, and pharmacogenomics. Recent innovations such as PCR, NGS, and microarrays have enhanced test sensitivity and specificity, enabling quicker and more accurate diagnoses. The market is notably expanding due to rising rates of infectious diseases like HIV and hepatitis, coupled with an aging population and escalating chronic disease prevalence, necessitating reliable molecular diagnostics for early detection and targeted treatments. Key players including Abbott, Roche, and Thermo Fisher are actively pursuing strategic partnerships and product innovations to strengthen their market position.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Molecular Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Molecular Diagnostics Market Segments Analysis

Global Molecular Diagnostics Market is segmented by Product, Test Type, Sample Type, Technology, Application, End User and region. Based on Product, the market is segmented into Reagents & Kits, Instruments and Services & Software. Based on Test Type, the market is segmented into Lab Tests and POC Tests. Based on Sample Type, the market is segmented into Blood, Serum, And Plasma, Urine and Other Sample Types. Based on Technology, the market is segmented into Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-Generation Sequencing, In Situ Hybridization, DNA Microarrays and Other Technologies. Based on Application, the market is segmented into Infectious Disease Diagnostics, Oncology Testing, Genetic Testing and Other Applications. Based on End User, the market is segmented into Diagnostic Laboratories, Hospitals & Clinics and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Molecular Diagnostics Market

The global molecular diagnostics market is being significantly propelled by the rapid advancements in technologies such as Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), and microarray technologies. These innovations have transformed the landscape of molecular diagnostics, leading to a marked improvement in the accuracy, sensitivity, and speed of diagnostic tests. As a result, the enhanced performance of these diagnostic tools has fostered greater market growth, enabling healthcare professionals to deliver more precise and timely results. This continuous evolution of diagnostic technology plays a crucial role in expanding the overall molecular diagnostics market, meeting the increasing demand for effective healthcare solutions.

Restraints in the Global Molecular Diagnostics Market

Despite the high accuracy and effectiveness of molecular diagnostic tests, their implementation is often hindered by high costs, particularly in developing regions where healthcare budgets are limited. The expenses associated with the necessary testing equipment, reagents, and the skilled personnel required for molecular testing can be substantial. This financial burden places considerable strain on healthcare facilities in these areas, ultimately restricting the growth of the Global Molecular Diagnostics market. Without addressing these cost-related challenges, widespread adoption and accessibility of molecular diagnostics remain a significant hurdle, hampering potential advancements in patient care and disease management.

Market Trends of the Global Molecular Diagnostics Market

The Global Molecular Diagnostics market is experiencing a significant shift towards point-of-care testing, propelled by the increasing demand for rapid diagnosis and effective treatment monitoring. This trend spans a variety of healthcare environments, including clinics, emergency rooms, and mobile health units, as healthcare providers prioritize timely interventions. Innovations in miniaturized and portable molecular diagnostic devices are facilitating real-time testing outside conventional laboratory settings, thereby improving patient care and operational efficiency. As a result, the market is witnessing an expansion in product offerings and technologies designed to meet the evolving needs of clinicians and patients alike, highlighting a transformative evolution in healthcare delivery.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Patent Analysis
• Regulatory Analysis
• Technology Analysis
• Case Studies

Global Molecular Diagnostics Market Size by Product & Service & CAGR (2025-2032)

• Market Overview
• Reagents & Kits
• Instruments
• Services & Software

Global Molecular Diagnostics Market Size by Test Type & CAGR (2025-2032)

• Market Overview
• Lab Tests
• POC Tests

Global Molecular Diagnostics Market Size by Sample Type & CAGR (2025-2032)

• Market Overview
• Blood, Serum, And Plasma
• Urine
• Other Sample Types

Global Molecular Diagnostics Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Polymerase Chain Reaction
• Isothermal Nucleic Acid Amplification Technology
• DNA Sequencing & Next-Generation Sequencing
• In Situ Hybridization
• DNA Microarrays
• Other Technologies

Global Molecular Diagnostics Market Size by Application & CAGR (2025-2032)

• Market Overview
• Infectious Disease Diagnostics
  • Hepatitis
  • Hepatitis B
  • Hepatitis C
  • Other hepatitis diseases
  • HIV
  • CT/NG
  • HAI
  • HPV
  • Tuberculosis
  • Influenza
  • Other Infectious Diseases
• Oncology Testing
  • Breast Cancer
  • Colorectal Cancer
  • Lung Cancer
  • Prostate Cancer
  • Other Cancer Types
• Genetic Testing
• Other Applications

Global Molecular Diagnostics Market Size by End User & CAGR (2025-2032)

• Market Overview
• Diagnostic Laboratories
• Hospitals & Clinics
• Other End Users

Global Molecular Diagnostics Market Size & CAGR (2025-2032)

• North America (Product & Service, Test Type, Sample Type, Technology, Application, End User)
  • US
  • Canada
• Europe (Product & Service, Test Type, Sample Type, Technology, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Service, Test Type, Sample Type, Technology, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Service, Test Type, Sample Type, Technology, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Service, Test Type, Sample Type, Technology, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton Dickinson And Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quidel Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocartis (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myriad Genetics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MDxHealth (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OncoCyte Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations